FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1653-1654 June 15, 1995 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The Italian Group for Antiemetic Research

To the Editor: The article on the use of granisetron and dexamethasone to prevent chemotherapy-induced nausea and vomiting (Jan. 5 issue)¹ does not appear to be relevant to current practice in the United States. The study group used 3 mg of granisetron, which is triple the dose recommended to provide an effect equivalent to that of 32 mg of ondansetron. Furthermore, a simple economic analysis makes it clear that this dose would be exceedingly unappealing to any purchaser of health care. At a rock-bottom cost of $135 per milligram of granisetron, each treatment would cost approximately $400. Since the study . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.